Biography
With a wealth of experience spanning decades in Research and Development, Eric stands out as a distinguished figure in the biopharmaceutical industry.
His track record of highly diverse accomplishments includes significant contributions to 3 NDA approvals, integration of 6 major M&As, and leading strategic initiatives that optimized the ROI of R&D allowing for further reinvestment in novel therapeutic modalities and indications.
As a Senior Advisor at G&L, Eric ensures that G&L remains at the forefront of global regulatory affairs optimization.
A pivotal member of the G&L Executive Team and Board, he plays a crucial role in shaping and executing strategic plans vital for the sustained growth and development of the company.
His support reflects a commitment to innovation, efficiency, and strategic foresight, propelling G&L to new heights within the pharmaceutical landscape.
